9 résultats : biomarker

Attention : l'accès aux ressources peut être restreint, soit pour des raisons juridiques, soit par la volonté de l'auteur.
9 résultats
page 1 sur 1
résultats 1 à 9
Canal-U
Cardiovascular Clinical Trialists (CVCT) Forum – Paris 2012 : Best statistical methods for evaluating the merits of a novel marker
Description : Title : Cardiovascular Clinical Trialists (CVCT) Forum – Paris 2012 : Best statistical methods for evaluating the merits of a novel marker Speaker: Stefan BLANKENBERG, Hamburg, GER Discussant: Nancy GELLER, Bethesda, USA Abstract : Best statistical methods for evaluating the merits of a novel ma ...
Mots clés : Cardiovascular Clinical Trialists, Paris, 2012, Cardiovascular prevention, cardiovascular pharmacology, biomarker
Date : 01-12-2012
Droits : Droits réservés à l'éditeur et aux auteurs.
 En savoir plus
 Description complète
Cardiovascular Clinical Trialists (CVCT) Forum – Paris 2012 : Best statistical methods for evaluating the merits of a novel marker
 Ajouter à mon panier
Accéder aux documents
Canal-U
Cardiovascular Clinical Trialists (CVCT) Forum – Paris 2012 : debate : Best statistical methods for evaluating the merits of a novel marker (debates).
Description : Title : Cardiovascular Clinical Trialists (CVCT) Forum – Paris 2012 : debate : Best statistical methods for evaluating the merits of a novel marker (debates). Speaker: Stefan BLANKENBERG, Hamburg, GER Discussant: Nancy GELLER, Bethesda, USA Abstract : debate : Best statistical methods for evaluating ...
Mots clés : Cardiovascular Clinical Trialists, Paris, 2012, Cardiovascular prevention, cardiovascular pharmacology, biomarker
Date : 01-12-2012
Droits : Droits réservés à l'éditeur et aux auteurs.
 En savoir plus
 Description complète
Cardiovascular Clinical Trialists (CVCT) Forum – Paris 2012 : debate : Best statistical methods for evaluating the merits of a novel marker (debates).
 Ajouter à mon panier
Accéder aux documents
Canal-U
EN-6. Biomonitoring
Description : Stellio Casas presents the biomonitoring. This tool of biodiversity management can be used for the different biological levels of the life. It leads to the identification of bioaccumulators, biomarkers and biodiversity indications.
Mots clés : biodiversity, bioindicator, biomonitoring, bioaccumulator, biomarker, biodiversity indication
Date : 28-11-2014
Droits : Droits réservés à l'éditeur et aux auteurs. Licence Creative Commons : Paternité, Pas d'utilisation commerciale, Pas de modification
 En savoir plus
 Description complète
EN-6. Biomonitoring
 Ajouter à mon panier
Accéder aux documents
Canal-U
Cardiovascular Clinical Trialists (CVCT) Forum – Paris 2012 : Biomarker guided-therapy: Are there other endpoints besides mortality that matter? Selecting the best outcome measures
Description : Title : Cardiovascular Clinical Trialists (CVCT) Forum – Paris 2012 : Biomarker guided-therapy: Are there other endpoints besides mortality that matter? Selecting the best outcome measures Speaker: Michael FELKER, Durham, USA Abstract : Biomarker guided-therapy: Are there other endpoints besides ...
Mots clés : Cardiovascular Clinical Trialists, Paris, 2012, Cardiovascular prevention, cardiovascular pharmacology, biomarker
Date : 01-12-2012
Droits : Droits réservés à l'éditeur et aux auteurs.
 En savoir plus
 Description complète
Cardiovascular Clinical Trialists (CVCT) Forum – Paris 2012 : Biomarker guided-therapy: Are there other endpoints besides mortality that matter? Selecting the best outcome measures
 Ajouter à mon panier
Accéder aux documents
Canal-U
Cardiovascular Clinical Trialists (CVCT) Forum – Paris 2012 : Debate led by Journal Editors: There are too many studies and the quality is variable. Should there be a position statement establishing rules for biomarker studies?
Description : Title : Cardiovascular Clinical Trialists (CVCT) Forum – Paris 2012 : Debate led by Journal Editors: There are too many studies and the quality is variable. Should there be a position statement establishing rules for biomarker studies? John JARCHO, Boston, USA, NEJM Rita REDBERG, San Francisco, ...
Mots clés : Cardiovascular Clinical Trialists, Paris, 2012, Cardiovascular prevention, cardiovascular pharmacology, biomarker
Date : 01-12-2012
Droits : Droits réservés à l'éditeur et aux auteurs.
 En savoir plus
 Description complète
Cardiovascular Clinical Trialists (CVCT) Forum – Paris 2012 : Debate led by Journal Editors: There are too many studies and the quality is variable. Should there be a position statement establishing rules for biomarker studies?
 Ajouter à mon panier
Accéder aux documents
Canal-U
Cardiovascular Clinical Trialists (CVCT) Forum – Paris 2012 : Best statistical methods for evaluating the merits of a novel marker
Description : Title : Cardiovascular Clinical Trialists (CVCT) Forum – Paris 2012 : Best statistical methods for evaluating the merits of a novel marker Speaker: Stefan BLANKENBERG, Hamburg, GER Discussant: Nancy GELLER, Bethesda, USA Abstract : Best statistical methods for evaluating the merits of a novel ma ...
Mots clés : Cardiovascular Clinical Trialists, Paris, 2012, Cardiovascular prevention, cardiovascular pharmacology, biomarker
Date : 01-12-2012
Droits : Droits réservés à l'éditeur et aux auteurs.
 En savoir plus
 Description complète
Cardiovascular Clinical Trialists (CVCT) Forum – Paris 2012 : Best statistical methods for evaluating the merits of a novel marker
 Ajouter à mon panier
Accéder aux documents
Canal-U
Cardiovascular Clinical Trialists (CVCT) Forum – Paris 2012 : How should diagnostic/prognostic markers be studied?
Description : Title : Cardiovascular Clinical Trialists (CVCT) Forum – Paris 2012 : How should diagnostic/prognostic markers be studied? Speaker: Jim JANUZZI, Boston, USA Discussant: James SNIDER, Critical Diagnostics, USA Abstract : How should Diagnostic and Prognostic Markers Be Studied? The measurement of ...
Mots clés : Cardiovascular Clinical Trialists, Paris, 2012, Cardiovascular prevention, cardiovascular pharmacology, biomarker
Date : 01-12-2012
Droits : Droits réservés à l'éditeur et aux auteurs.
 En savoir plus
 Description complète
Cardiovascular Clinical Trialists (CVCT) Forum – Paris 2012 : How should diagnostic/prognostic markers be studied?
 Ajouter à mon panier
Accéder aux documents
Canal-U
Cardiovascular Clinical Trialists (CVCT) Forum – Paris 2012 : Debate led by Journal Editors: There are too many studies and the quality is variable. Should there be a position statement establishing rules for biomarker studies?
Description : Title : Cardiovascular Clinical Trialists (CVCT) Forum – Paris 2012 : Debate led by Journal Editors: There are too many studies and the quality is variable. Should there be a position statement establishing rules for biomarker studies? John JARCHO, Boston, USA, NEJM Rita REDBERG, San Francisco, ...
Mots clés : Cardiovascular Clinical Trialists, Paris, 2012, Cardiovascular prevention, cardiovascular pharmacology, biomarker
Date : 01-12-2012
Droits : Droits réservés à l'éditeur et aux auteurs.
 En savoir plus
 Description complète
Cardiovascular Clinical Trialists (CVCT) Forum – Paris 2012 : Debate led by Journal Editors: There are too many studies and the quality is variable. Should there be a position statement establishing rules for biomarker studies?
 Ajouter à mon panier
Accéder aux documents
Canal-U
Cardiovascular Clinical Trialists (CVCT) Forum – Paris 2012 : How should diagnostic/prognostic markers be studied?
Description : Title : Cardiovascular Clinical Trialists (CVCT) Forum – Paris 2012 : How should diagnostic/prognostic markers be studied? Speaker: Jim JANUZZI, Boston, USA Discussant: James SNIDER, Critical Diagnostics, USA Abstract : How should Diagnostic and Prognostic Markers Be Studied? The measurement of ...
Mots clés : Cardiovascular Clinical Trialists, Paris, 2012, Cardiovascular prevention, cardiovascular pharmacology, biomarker
Date : 01-12-2012
Droits : Droits réservés à l'éditeur et aux auteurs.
 En savoir plus
 Description complète
Cardiovascular Clinical Trialists (CVCT) Forum – Paris 2012 : How should diagnostic/prognostic markers be studied?
 Ajouter à mon panier
Accéder aux documents